TALIMOGENE LAHERPAREPVEC for Malignant melanoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 562 adverse event reports in the FDA FAERS database where TALIMOGENE LAHERPAREPVEC was used for Malignant melanoma.

Most Reported Side Effects for TALIMOGENE LAHERPAREPVEC

Side Effect	Reports	%	Deaths	Hosp.
Off label use	196	13.3%	25	25
Pyrexia	135	9.2%	9	38
Product storage error	133	9.0%	0	0
Metastatic malignant melanoma	109	7.4%	42	10
Circumstance or information capable of leading to medication error	89	6.0%	0	0
Death	82	5.6%	82	9
Influenza like illness	82	5.6%	6	14
Fatigue	70	4.8%	6	12
Chills	68	4.6%	3	13
Malignant melanoma	64	4.3%	15	9
Therapy partial responder	56	3.8%	12	5
Therapy non-responder	50	3.4%	8	3
Injection site pain	47	3.2%	3	5
Oral herpes	47	3.2%	1	0
Nausea	46	3.1%	6	9